237 related articles for article (PubMed ID: 21536658)
1. Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.
Janas JA; Van Aelst L
Mol Cell Biol; 2011 Jul; 31(13):2552-65. PubMed ID: 21536658
[TBL] [Abstract][Full Text] [Related]
2. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).
Di Cristofano A; Niki M; Zhao M; Karnell FG; Clarkson B; Pear WS; Van Aelst L; Pandolfi PP
J Exp Med; 2001 Aug; 194(3):275-84. PubMed ID: 11489947
[TBL] [Abstract][Full Text] [Related]
3. Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins.
Bhat A; Johnson KJ; Oda T; Corbin AS; Druker BJ
J Biol Chem; 1998 Nov; 273(48):32360-8. PubMed ID: 9822717
[TBL] [Abstract][Full Text] [Related]
4. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
[TBL] [Abstract][Full Text] [Related]
5. Role of Dok-1 and Dok-2 in leukemia suppression.
Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins.
Di Cristofano A; Carpino N; Dunant N; Friedland G; Kobayashi R; Strife A; Wisniewski D; Clarkson B; Pandolfi PP; Resh MD
J Biol Chem; 1998 Feb; 273(9):4827-30. PubMed ID: 9478921
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.
Liang X; Wisniewski D; Strife A; Shivakrupa ; Clarkson B; Resh MD
J Biol Chem; 2002 Apr; 277(16):13732-8. PubMed ID: 11825908
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel member of the DOK family that binds and modulates Abl signaling.
Cong F; Yuan B; Goff SP
Mol Cell Biol; 1999 Dec; 19(12):8314-25. PubMed ID: 10567556
[TBL] [Abstract][Full Text] [Related]
9. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B
Cell; 1997 Jan; 88(2):197-204. PubMed ID: 9008160
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.
Kashige N; Carpino N; Kobayashi R
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2093-8. PubMed ID: 10688886
[TBL] [Abstract][Full Text] [Related]
11. Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.
Zhao M; Janas JA; Niki M; Pandolfi PP; Van Aelst L
Mol Cell Biol; 2006 Apr; 26(7):2479-89. PubMed ID: 16537894
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1.
Okabe S; Fukuda S; Kim YJ; Niki M; Pelus LM; Ohyashiki K; Pandolfi PP; Broxmeyer HE
Blood; 2005 Jan; 105(2):474-80. PubMed ID: 15345598
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase.
Gérard A; Favre C; Garçon F; Némorin JG; Duplay P; Pastor S; Collette Y; Olive D; Nunès JA
Oncogene; 2004 Feb; 23(8):1594-8. PubMed ID: 14647425
[TBL] [Abstract][Full Text] [Related]
14. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
[TBL] [Abstract][Full Text] [Related]
15. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
[TBL] [Abstract][Full Text] [Related]
16. Bag1 directly routes immature BCR-ABL for proteasomal degradation.
Tsukahara F; Maru Y
Blood; 2010 Nov; 116(18):3582-92. PubMed ID: 20675402
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of SHIP promotes its proteasomal degradation.
Ruschmann J; Ho V; Antignano F; Kuroda E; Lam V; Ibaraki M; Snyder K; Kim C; Flavell RA; Kawakami T; Sly L; Turhan AG; Krystal G
Exp Hematol; 2010 May; 38(5):392-402, 402.e1. PubMed ID: 20304029
[TBL] [Abstract][Full Text] [Related]
19. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration.
Noguchi T; Matozaki T; Inagaki K; Tsuda M; Fukunaga K; Kitamura Y; Kitamura T; Shii K; Yamanashi Y; Kasuga M
EMBO J; 1999 Apr; 18(7):1748-60. PubMed ID: 10202139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
